yoga-mahendra
Three scientists whose work gave researchers the power to switch individual nerve cells on and off with light have been honoured with this year's Nobel Prize in Physiology or Medicine. US psychiatrist and neurologist Karl Deisseroth shares the award with his German colleagues Peter Hegemann and Georg Nagel for founding and developing the field of optogenetics, a technique that has transformed how scientists probe the inner workings of the human brain.
The Nobel committee announced the prize in recognition of research that it said laid the foundation for a new era in neuroscience. According to the committee, the trio's discoveries have made it possible to reveal the neural circuits responsible for "specific memories, feelings, and behaviours relevant for neurological and psychiatric disorders", offering an unprecedented window into the biological machinery behind emotion and thought.
At its core, optogenetics combines genetics and optics to control precisely targeted cells. Researchers introduce light-sensitive proteins into neurons, then deliver pulses of light to trigger or silence those cells. The approach allows experiments that were once unimaginable, letting scientists watch what happens when a single circuit deep inside the brain is activated or suppressed while an animal goes about its behaviour.
The prize places Deisseroth, Hegemann and Nagel at the centre of a scientific revolution that now spans laboratories around the world. Deisseroth, based in the United States, is widely credited with driving the technique's application in brain research, while Hegemann and Nagel, working in Germany, made essential contributions by identifying and characterising the light-sensitive molecules that make the method possible.
The committee's citation emphasised how profoundly the work has changed neuroscience, describing the trio as having opened a new chapter in the study of the brain. Rather than merely observing brain activity from the outside, researchers can now intervene directly in defined sets of neurons and observe the consequences, a shift that has reshaped experimental design across the field.
The implications for medicine are already becoming apparent. In clinical research, scientists are using the optogenetic method in efforts to try to restore sight in people with visual impairment. By introducing light-sensitive proteins into surviving cells of the eye and stimulating them with light, researchers hope to recreate signals that the brain can interpret as vision, an approach that could one day benefit patients whose photoreceptors have degenerated.
Understanding the circuits that underlie memory, emotion and behaviour carries particular weight for psychiatry, where conditions such as depression, anxiety and addiction remain difficult to treat. Being able to pinpoint the exact neural pathways involved in a given behaviour or feeling could help explain why some people develop these disorders and how treatments might be designed to correct faulty wiring.
The award also reflects a broader trend in modern biology, in which tools borrowed from physics, genetics and engineering are brought together to answer questions about living systems. Optogenetics is a striking example of that convergence, requiring expertise in protein biology, optics and behavioural science, and its success has encouraged similar cross-disciplinary efforts in other areas of research.
For those who study learning and memory, the method has proven especially valuable. It has allowed scientists to test long-standing theories about where memories are stored and how they are retrieved, moving debates from speculation toward direct experimental evidence. The Nobel committee's reference to "specific memories" underscores how central such questions have become to the field.
Deisseroth's background in both psychiatry and neurology is notable, bridging the clinic and the laboratory. His interest in understanding mental illness at the level of neural circuits aligns with a growing conviction among researchers that psychiatric conditions should be investigated as disorders of specific brain pathways rather than as vague disturbances of the mind.
Hegemann and Nagel's contribution came from the study of light-sensitive proteins found in simple organisms, work that initially appeared far removed from human medicine. Their identification of molecules that respond to light by moving charged particles across cell membranes provided the crucial component that made controlling neurons with light feasible, illustrating how basic research can yield tools of enormous practical value.
The prize is likely to accelerate interest in optogenetics and related techniques, drawing new funding and talent into neuroscience. As the toolkit expands, researchers are developing ever more refined ways to target cells, including approaches that use different colours of light to control multiple circuits at once, further increasing the precision of experiments.
Beyond vision restoration, scientists are exploring whether similar strategies might eventually be adapted to treat conditions affecting movement, such as Parkinson's disease, or to modulate abnormal activity in epilepsy. These remain experimental avenues, and much work is needed before such treatments could reach patients, but the underlying principle of controlling cells with light has moved from concept to credible research programme.
The recognition also carries symbolic weight for the field of brain research as a whole. For decades, neuroscientists lacked tools capable of matching the complexity of the organ they studied, and the ability to manipulate individual circuits has changed both the kinds of questions asked and the confidence with which answers can be given.
This year's laureates join a long line of medicine prize winners whose work has reshaped entire disciplines. Theirs is a story of how curiosity about light-sensing proteins and the electrical behaviour of cells converged with a clinician's drive to understand mental illness, producing a method that continues to reveal how nerve cells shape the feelings, memories and behaviours that make us who we are.
Comments (0)